Blood glucose monitoring study
This article was originally published in The Gray Sheet
Executive SummaryResults of the "Diabetes Control and Complication Trial" released at an American Diabetes Association meeting June 13 in Las Vegas indicate that intensive monitoring of blood glucose levels result in a "delay in the onset and a major slowing of the progression of" complications in patients with Type I diabetes (insulin-dependent diabetes mellitus). The ADA notes, however, that the results of the 1,441- patient study may not apply to people with non-insulin- dependent diabetes mellitus.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.